skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Insights into DNA substrate selection by APOBEC3G from structural, biochemical, and functional studies

Journal Article · · PLoS ONE
 [1];  [1];  [2];  [1];  [3];  [1];  [4];  [3];  [3];  [2]; ORCiD logo [1]
  1. Yale Univ., New Haven, CT (United States)
  2. Yale Univ., New Haven, CT (United States); Yale Univ. School of Medicine, New Haven, CT (United States)
  3. National Cancer Inst. at Frederick, MD (United States)
  4. Yale Univ. School of Medicine, New Haven, CT (United States)

Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3 (A3) proteins are a family of cytidine deaminases that catalyze the conversion of deoxycytidine (dC) to deoxyuridine (dU) in single-stranded DNA (ssDNA). A3 proteins act in the innate immune response to viral infection by mutating the viral ssDNA. One of the most well-studied human A3 family members is A3G, which is a potent inhibitor of HIV-1. Each A3 protein prefers a specific substrate sequence for catalysis—for example, A3G deaminates the third dC in the CCCA sequence motif. However, the interaction between A3G and ssDNA is difficult to characterize due to poor solution behavior of the full-length protein and loss of DNA affinity of the truncated protein. Here, we present a novel DNA-anchoring fusion strategy using the protection of telomeres protein 1 (Pot1) which has nanomolar affinity for ssDNA, with which we captured an A3G-ssDNA interaction. We crystallized a non-preferred adenine in the -1 nucleotide-binding pocket of A3G. The structure reveals a unique conformation of the catalytic site loops that sheds light onto how the enzyme scans substrate in the -1 pocket. Furthermore, our biochemistry and virology studies provide evidence that the nucleotide-binding pockets on A3G influence each other in selecting the preferred DNA substrate. Together, the results provide insights into the mechanism by which A3G selects and deaminates its preferred substrates and help define how A3 proteins are tailored to recognize specific DNA sequences. This knowledge contributes to a better understanding of the mechanism of DNA substrate selection by A3G, as well as A3G antiviral activity against HIV-1.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); National Science Foundation (NSF); USDOD; National Cancer Institute (NCI); Center for Cancer Research; Intramural AIDS Targeted Antiviral Program
Grant/Contract Number:
AI116313; GM49551; 1F31CA203254-01; T32GM007223; 5T32AI007019-40; DGE-1122492; W81XWH-15-1-0290
OSTI ID:
1433702
Journal Information:
PLoS ONE, Vol. 13, Issue 3; ISSN 1932-6203
Publisher:
Public Library of ScienceCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 21 works
Citation information provided by
Web of Science

References (59)

APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase journal April 2004
The Restriction Factors of Human Immunodeficiency Virus journal October 2012
Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G journal February 2008
Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation journal May 2016
The AID/APOBEC family of nucleic acid mutators journal January 2008
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity journal April 2017
Signatures of mutational processes in human cancer journal August 2013
Crystal structures of APOBEC3G N-domain alone and its complex with DNA journal August 2016
REFMAC 5 dictionary: organization of prior chemical knowledge and guidelines for its use journal November 2004
Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity journal September 2009
Determinants of sequence-specificity within human AID and APOBEC3G journal May 2010
Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All journal March 2014
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome journal April 2004
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA journal April 2006
Retroviral restriction by APOBEC proteins journal November 2004
The Local Dinucleotide Preference of APOBEC3G Can Be Altered from 5′-CC to 5′-TC by a Single Amino Acid Substitution journal November 2013
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B journal December 2016
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers journal July 2013
DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA journal November 2003
Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression journal February 2004
An Extended Structure of the APOBEC3G Catalytic Domain Suggests a Unique Holoenzyme Model journal June 2009
Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases journal May 2016
Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G journal September 2007
Cytokine Signals Are Sufficient for HIV-1 Infection of Resting Human T Lymphocytes journal June 1999
Crystal Structure of the APOBEC3G Catalytic Domain Reveals Potential Oligomerization Interfaces journal January 2010
APOBEC3 proteins can copackage and comutate HIV-1 genomes journal July 2016
APOBEC3B is an enzymatic source of mutation in breast cancer journal February 2013
Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction journal February 2007
Coot model-building tools for molecular graphics journal November 2004
Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID journal January 2010
APOBEC proteins and intrinsic resistance to HIV-1 infection journal November 2008
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications journal October 2008
Target DNA Sequence Directly Regulates the Frequency of Activation-Induced Deaminase-Dependent Mutations journal September 2012
Mechanistic Studies to Understand the Progressive Development of Resistance in Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Abacavir journal August 2002
Coupling between trans/cis proline isomerization and protein stability in staphylococcal nuclease journal September 1996
Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance journal April 2009
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein journal July 2002
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts journal May 2003
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins journal August 2004
APOBEC3 proteins mediate the clearance of foreign DNA from human cells journal January 2010
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) journal September 2000
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
APOBEC3G: an intracellular centurion journal November 2008
Phaser crystallographic software journal July 2007
Signatures of mutational processes in human cancer. text January 2013
A Novel Cytidine Deaminase Affects Antibody Diversity journal September 2000
Human cells clear foreign DNA journal February 2010
Nanostructures of APOBEC3G Support a Hierarchical Assembly Model of High Molecular Mass Ribonucleoprotein Particles from Dimeric Subunits journal October 2006
A Portable Hot Spot Recognition Loop Transfers Sequence Preferences from APOBEC Family Members to Activation-induced Cytidine Deaminase journal June 2009
Local Sequence Targeting in the AID/APOBEC Family Differentially Impacts Retroviral Restriction and Antibody Diversification journal October 2010
Crystal Structure of DNA Cytidine Deaminase ABOBEC3G Catalytic Deamination Domain Suggests a Binding Mode of Full-length Enzyme to Single-stranded DNA journal December 2014
DNA Substrate Length and Surrounding Sequence Affect the Activation-induced Deaminase Activity at Cytidine journal November 2003
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy journal June 2002
APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis journal May 2010
Identification of Two Distinct Human Immunodeficiency Virus Type 1 Vif Determinants Critical for Interactions with Human APOBEC3G and APOBEC3F journal May 2007
HIV-1 and HIV-2 Vif Interact with Human APOBEC3 Proteins Using Completely Different Determinants journal June 2014
Identification of Specific Determinants of Human APOBEC3F, APOBEC3C, and APOBEC3DE and African Green Monkey APOBEC3F That Interact with HIV-1 Vif journal October 2010
Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif journal November 2008
A Comparison of Two Single-Stranded DNA Binding Models by Mutational Analysis of APOBEC3G journal August 2012

Cited By (1)

Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA journal June 2019